Table 3.
Group sizes, data range, median, and IQR for residual infarct sizes obtained 9 days post MCAo
| Variable | Residual infarct size (%) | ||||
|---|---|---|---|---|---|
| Treatment (number of ASCs) | MCAo (min) | Animals (n) | Data range | Median | IQR |
| Control | 45 | 5 | 32.16 to 74.84 | 51.1 | 25.53 |
| 90 | 4 | ||||
| 5 × 104 | 45 | 7 | 13.52 to 60.17 | 45.02 | 37.7 |
| 3 × 105 | 45 | 6 | 27.16 to 56.4 | 37.84 | 7.14 |
| 90 | 1 | ||||
| 1 × 106 | 45 | 3 | 27.31 to 67.46 | 53.6 | 24.89 |
| 90 | 2 | ||||
ASC adipose tissue-derived stem cell, IQR interquartile range, MCAo middle cerebral artery occlusion